Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2015 1
2017 4
2018 6
2019 5
2020 2
2021 5
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Hearing optimisation in neurofibromatosis type 2: A systematic review.
Lloyd SKW, King AT, Rutherford SA, Hammerbeck-Ward CL, Freeman SRM, Mawman DJ, O'Driscoll M, Evans DG. Lloyd SKW, et al. Clin Otolaryngol. 2017 Dec;42(6):1329-1337. doi: 10.1111/coa.12882. Epub 2017 Apr 26. Clin Otolaryngol. 2017. PMID: 28371358 Review.
BACKGROUND: It is common for patients with neurofibromatosis type 2 to develop bilateral profound hearing loss hearing loss, and this is one of the main determinants of quality of life in this patient group. OBJECTIVES: The aim of this systematic review was t …
BACKGROUND: It is common for patients with neurofibromatosis type 2 to develop bilateral profound hearing loss hearing …
A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas.
Chung LK, Nguyen TP, Sheppard JP, Lagman C, Tenn S, Lee P, Kaprealian T, Chin R, Gopen Q, Yang I. Chung LK, et al. World Neurosurg. 2018 Jan;109:47-58. doi: 10.1016/j.wneu.2017.08.159. Epub 2017 Sep 4. World Neurosurg. 2018. PMID: 28882713 Review.
OBJECTIVE: Neurofibromatosis type 2 (NF2) is an autosomal dominant disease characterized by bilateral vestibular schwannomas (VSs). ...
OBJECTIVE: Neurofibromatosis type 2 (NF2) is an autosomal dominant disease characterized by bilateral vestibular schwan …
A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.
Acar S, Nieblas-Bedolla E, Armstrong AE, Hirbe AC. Acar S, et al. Pediatr Neurol. 2022 Sep;134:1-6. doi: 10.1016/j.pediatrneurol.2022.06.003. Epub 2022 Jun 10. Pediatr Neurol. 2022. PMID: 35759947 Free article. Review.
INTRODUCTION: The neurofibromatoses comprise three different genetic conditions causing considerable morbidity and mortality: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis (SWN). This review summarizes recent and ongoing …
INTRODUCTION: The neurofibromatoses comprise three different genetic conditions causing considerable morbidity and mortality: neurofibromato …
Indications and contraindications of auditory brainstem implants: systematic review and illustrative cases.
Merkus P, Di Lella F, Di Trapani G, Pasanisi E, Beltrame MA, Zanetti D, Negri M, Sanna M. Merkus P, et al. Eur Arch Otorhinolaryngol. 2014 Jan;271(1):3-13. doi: 10.1007/s00405-013-2378-3. Epub 2013 Feb 13. Eur Arch Otorhinolaryngol. 2014. PMID: 23404468 Review.
The number of non-neurofibromatosis type 2 (NF2) indications for auditory brainstem implant (ABI) in the literature is increasing. ...
The number of non-neurofibromatosis type 2 (NF2) indications for auditory brainstem implant (ABI) in the literature is …
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis.
Tosi U, Maayan O, An A, Lavieri MET, Guadix SW, DeRosa AP, Christos PJ, Pannullo S, Stieg PE, Brandmaier A, Knisely JPS, Ramakrishna R. Tosi U, et al. J Neurooncol. 2022 Jan;156(2):431-441. doi: 10.1007/s11060-021-03910-8. Epub 2022 Jan 18. J Neurooncol. 2022. PMID: 35040021
INTRODUCTION: Neurofibromatosis type 2 (NF2) is characterized by often bilateral vestibular schwannomas (VS) that result in progressive hearing loss and compression of nearby brainstem structures causing cranial nerve palsies. ...
INTRODUCTION: Neurofibromatosis type 2 (NF2) is characterized by often bilateral vestibular schwannomas (VS) that resul …
Systematic Review of Nontumor Pediatric Auditory Brainstem Implant Outcomes.
Noij KS, Kozin ED, Sethi R, Shah PV, Kaplan AB, Herrmann B, Remenschneider A, Lee DJ. Noij KS, et al. Otolaryngol Head Neck Surg. 2015 Nov;153(5):739-50. doi: 10.1177/0194599815596929. Epub 2015 Jul 30. Otolaryngol Head Neck Surg. 2015. PMID: 26227469 Review.
OBJECTIVE: The auditory brainstem implant (ABI) was initially developed for patients with deafness as a result of neurofibromatosis type 2. ABI indications have recently extended to children with congenital deafness who are not cochlear implant candidates. .. …
OBJECTIVE: The auditory brainstem implant (ABI) was initially developed for patients with deafness as a result of neurofibromatosis …
Reliability and toxicity of bevacizumab for neurofibromatosis type 2-related vestibular schwannomas: A systematic review and meta-analysis.
Shi J, Lu D, Gu R, Sun H, Yu L, Pan R, Zhang Y. Shi J, et al. Am J Otolaryngol. 2021 Nov-Dec;42(6):103148. doi: 10.1016/j.amjoto.2021.103148. Epub 2021 Jun 26. Am J Otolaryngol. 2021. PMID: 34214711
BACKGROUND: The anti-angiogenic agent bevacizumab is currently the only drug used clinically for neurofibromatosis type 2-related vestibular schwannomas (NF2-VS). Though benefits have been demonstrated in several cases, the standardized dosage remains unclear …
BACKGROUND: The anti-angiogenic agent bevacizumab is currently the only drug used clinically for neurofibromatosis type 2 …
Clinical practice guideline on the management of vestibular schwannoma.
Lassaletta L, Acle Cervera L, Altuna X, Amilibia Cabeza E, Arístegui Ruiz M, Batuecas Caletrio Á, Benítez Del Rosario J, Cabanillas Farpón R, Costales Marcos M, Escada P, Espinosa-Sánchez JM, García Leal R, Gavilán J, Gómez Martínez J, González-Aguado R, Martinez-Glez V, Guerra Jiménez G, Harguindey Antolí-Candela A, Hernández García BJ, Orús Dotú C, Polo López R, Manrique M, Martín Sanz E, Martínez Álvarez R, Martínez H, Martínez-Martínez M, Rey-Martinez J, Ropero Romero F, Santa Cruz Ruiz S, Vallejo LÁ, Soto Varela A, Varela-Nieto I, Morales Puebla JM. Lassaletta L, et al. Acta Otorrinolaringol Esp (Engl Ed). 2024 Mar-Apr;75(2):108-128. doi: 10.1016/j.otoeng.2023.10.005. Epub 2024 Feb 10. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38346489
Long-term Hearing Preservation After Resection of Vestibular Schwannoma: A Systematic Review and Meta-analysis.
Ahsan SF, Huq F, Seidman M, Taylor A. Ahsan SF, et al. Otol Neurotol. 2017 Dec;38(10):1505-1511. doi: 10.1097/MAO.0000000000001560. Otol Neurotol. 2017. PMID: 29140965 Review.
Preoperative, immediate postoperative, and last follow-up audiograms were required. Exclusion criteria included neurofibromatosis type 2 patients and surgery for salvage therapy or decompression. ...
Preoperative, immediate postoperative, and last follow-up audiograms were required. Exclusion criteria included neurofibromatosis …
Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience.
Grossen A, Gavula T, Chrusciel D, Evans A, McNall-Knapp R, Taylor A, Fossey B, Brakefield M, Carter C, Schwartz N, Gross N, Jea A, Desai V. Grossen A, et al. Neurosurg Focus. 2022 May;52(5):E2. doi: 10.3171/2022.2.FOCUS21776. Neurosurg Focus. 2022. PMID: 35535824
Diagnoses were made based on clinical findings or results of genetic testing; 115 (70%) had neurofibromatosis type 1, 9 (5.5%) had neurofibromatosis type 2, 35 (21%) had tuberous sclerosis complex, 2 (1%) had von Hippel-Lindau syndrome, 2 (1%) had Gorlin synd …
Diagnoses were made based on clinical findings or results of genetic testing; 115 (70%) had neurofibromatosis type 1, 9 (5.5%) had neurof …
27 results